A detailed history of Wellington Management Group LLP transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Wellington Management Group LLP holds 31,532,725 shares of EW stock, worth $2.38 Billion. This represents 0.37% of its overall portfolio holdings.

Number of Shares
31,532,725
Previous 16,922,602 86.33%
Holding current value
$2.38 Billion
Previous $1.56 Billion 33.12%
% of portfolio
0.37%
Previous 0.29%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$59.7 - $93.78 $872 Million - $1.37 Billion
14,610,123 Added 86.33%
31,532,725 $2.08 Billion
Q2 2024

Aug 13, 2024

BUY
$84.3 - $94.31 $116 Million - $129 Million
1,372,843 Added 8.83%
16,922,602 $1.56 Billion
Q1 2024

May 15, 2024

BUY
$72.54 - $95.56 $1.13 Billion - $1.49 Billion
15,549,759 New
15,549,759 $1.49 Billion
Q4 2023

Feb 12, 2024

BUY
$61.71 - $77.76 $1.04 Billion - $1.31 Billion
16,827,510 New
16,827,510 $1.28 Billion
Q3 2023

Nov 14, 2023

BUY
$69.28 - $93.38 $96.3 Million - $130 Million
1,390,427 Added 9.24%
16,434,401 $1.14 Billion
Q2 2023

Aug 14, 2023

SELL
$81.41 - $94.33 $65.6 Million - $76 Million
-806,081 Reduced 5.09%
15,043,974 $1.42 Billion
Q1 2023

May 12, 2023

BUY
$74.26 - $84.51 $42.9 Million - $48.9 Million
578,319 Added 3.79%
15,850,055 $1.31 Billion
Q4 2022

Feb 13, 2023

BUY
$68.3 - $87.44 $42.7 Million - $54.6 Million
624,619 Added 4.26%
15,271,736 $1.14 Billion
Q3 2022

Nov 14, 2022

BUY
$82.37 - $107.29 $38.6 Million - $50.2 Million
468,181 Added 3.3%
14,647,117 $1.21 Billion
Q2 2022

Aug 15, 2022

SELL
$86.5 - $128.27 $70.5 Million - $104 Million
-814,587 Reduced 5.43%
14,178,936 $1.35 Billion
Q1 2022

May 16, 2022

SELL
$101.96 - $128.34 $61.8 Million - $77.8 Million
-606,517 Reduced 3.89%
14,993,523 $1.77 Billion
Q4 2021

Feb 11, 2022

SELL
$106.37 - $130.68 $84 Million - $103 Million
-789,362 Reduced 4.82%
15,600,040 $2.02 Billion
Q3 2021

Nov 15, 2021

SELL
$102.91 - $122.75 $36.5 Million - $43.6 Million
-354,990 Reduced 2.12%
16,389,402 $1.86 Billion
Q2 2021

Aug 16, 2021

BUY
$83.84 - $104.76 $17.8 Million - $22.3 Million
212,898 Added 1.29%
16,744,392 $1.73 Billion
Q1 2021

May 17, 2021

SELL
$78.68 - $90.67 $138 Million - $159 Million
-1,755,608 Reduced 9.6%
16,531,494 $1.38 Billion
Q4 2020

Feb 12, 2021

SELL
$71.69 - $91.23 $139 Million - $177 Million
-1,940,078 Reduced 9.59%
18,287,102 $1.67 Billion
Q3 2020

Nov 16, 2020

SELL
$67.19 - $87.44 $28.3 Million - $36.8 Million
-420,570 Reduced 2.04%
20,227,180 $1.61 Billion
Q2 2020

Aug 14, 2020

BUY
$57.54 - $76.95 $820 Million - $1.1 Billion
14,243,532 Added 222.41%
20,647,750 $1.43 Billion
Q1 2020

May 14, 2020

BUY
$52.41 - $81.0 $102 Million - $157 Million
1,940,741 Added 43.48%
6,404,218 $1.21 Billion
Q4 2019

Feb 11, 2020

BUY
$71.7 - $82.09 $320 Million - $366 Million
4,463,477 New
4,463,477 $1.04 Billion

Others Institutions Holding EW

About Edwards Lifesciences Corp


  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $46.6B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track Wellington Management Group LLP Portfolio

Follow Wellington Management Group LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wellington Management Group LLP, based on Form 13F filings with the SEC.

News

Stay updated on Wellington Management Group LLP with notifications on news.